Abbvie Inc banner

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 224.2066 USD -0.52%
Market Cap: $396.3B

Wall Street
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 255.679 USD with a low forecast of 189.5164 USD and a high forecast of 344.4 USD.

Lowest
Price Target
189.5164 USD
15% Downside
Average
Price Target
255.679 USD
14% Upside
Highest
Price Target
344.4 USD
54% Upside
Abbvie Inc Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
23% Upside
KRNY
Kearny Financial Corp
26% Upside
AFYA
Afya Ltd
28% Upside

Revenue
Forecast

9% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 14 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

Operating Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 14 years the compound annual growth rate for Abbvie Inc's operating income is 12%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

1% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss
1% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-52%
Average Miss

For the last 14 years the compound annual growth rate for Abbvie Inc's net income is 1%. The projected CAGR for the next 3 years is 97%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABBV's stock price target?
Price Target
255.679 USD

According to Wall Street analysts, the average 1-year price target for ABBV is 255.679 USD with a low forecast of 189.5164 USD and a high forecast of 344.4 USD.

What is Abbvie Inc's Revenue forecast?
Projected CAGR
9%

For the last 14 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 3 years is 9%.

What is Abbvie Inc's Operating Income forecast?
Projected CAGR
24%

For the last 14 years the compound annual growth rate for Abbvie Inc's operating income is 12%. The projected CAGR for the next 3 years is 24%.

What is Abbvie Inc's Net Income forecast?
Projected CAGR
97%

For the last 14 years the compound annual growth rate for Abbvie Inc's net income is 1%. The projected CAGR for the next 3 years is 97%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett